Sign In
Buy MRK
$120.78
+1.69 (+1.41%)
At Close: Jun 11, 2026
Merck (MRK) Stock Declines While Market Improves: Some Information for Investors
06:51pm, Tuesday, 07'th Apr 2026
The latest trading day saw Merck (MRK) settling at $119.28, representing a -1.3% change from its previous close.
Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review
02:28pm, Tuesday, 07'th Apr 2026
The deal consideration is $53.00 per share in cash for an approximate equity value of $6.7 billion.
Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought?
10:05am, Tuesday, 07'th Apr 2026
Two stocks retirement investors typically reach for in uncertain markets have risen notably in recent months.
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
09:00am, Tuesday, 07'th Apr 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding share
Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines
04:11pm, Monday, 06'th Apr 2026
Eli Lilly and peers like Novartis fuel a 2026 pharma M&A surge, striking billion-dollar deals to expand pipelines, tap AI innovation, and counter patent pressures.
Leo Wealth LLC Purchases 6,078 Shares of Merck & Co., Inc. $MRK
06:44am, Monday, 06'th Apr 2026
Leo Wealth LLC increased its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 29.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commissio
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc.
05:53am, Monday, 06'th Apr 2026
Savvy Advisors Inc. grew its position in shares of Merck and Co., Inc. (NYSE: MRK) by 50.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Ex
Merck Just Made a Big Bet on a New Cancer Growth Engine
10:41am, Sunday, 05'th Apr 2026
The drugmaker's stock recently got a shot in the arm on the news of it acquiring Terns Pharmaceutical—a move that will not only bolster its cancer treatment pipeline but also reinforce Merck's role
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (April 2026)
08:10am, Saturday, 04'th Apr 2026
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
Analyst IMS Investment Management Services Ltd. Boosts Stake in Merck & Co., Inc. $MRK
03:44am, Saturday, 04'th Apr 2026
Analyst IMS Investment Management Services Ltd. boosted its stake in Merck and Co., Inc. (NYSE: MRK) by 301.5% in the undefined quarter, according to its most recent filing with the SEC. The fund owne
10,200 Shares in Merck & Co., Inc. $MRK Purchased by FNY Investment Advisers LLC
06:36am, Friday, 03'rd Apr 2026
FNY Investment Advisers LLC acquired a new position in shares of Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
16,300 Shares in Merck & Co., Inc. $MRK Purchased by Dorato Capital Management
05:52am, Friday, 03'rd Apr 2026
Dorato Capital Management purchased a new position in shares of Merck and Co., Inc. (NYSE: MRK) during the undefined quarter, according to the company in its most recent Form 13F filing with the Secur
Eldred Rock Partners LLC Has $11.31 Million Stake in Merck & Co., Inc. $MRK
05:17am, Friday, 03'rd Apr 2026
Eldred Rock Partners LLC trimmed its position in Merck and Co., Inc. (NYSE: MRK) by 11.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exch
Beaumont Financial Advisors LLC Decreases Stake in Merck & Co., Inc. $MRK
04:36am, Friday, 03'rd Apr 2026
Beaumont Financial Advisors LLC cut its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 33.8% during the undefined quarter, according to its most recent Form 13F filing with the Securities an
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of a pivotal Phase 2b/3 trial evaluating MK-8748 (also known as T
